| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HUMIMM.2009.04.011 |
| P8608 | Fatcat ID | release_uq5npz2kabcjndmutvhytbypha |
| P698 | PubMed publication ID | 19375474 |
| P5875 | ResearchGate publication ID | 24306576 |
| P50 | author | Giuseppe Pantaleo | Q88061163 |
| P2093 | author name string | Vincent Aubert | |
| Manuel Pascual | |||
| Jean-Pierre Venetz | |||
| P433 | issue | 8 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 580-583 | |
| P577 | publication date | 2009-04-16 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant | |
| P478 | volume | 70 |
| Q34903473 | Accommodation in renal transplantation: unanswered questions |
| Q30586178 | An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival |
| Q61717674 | Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation |
| Q41849097 | Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. |
| Q35664894 | Application of calculated panel reactive antibody using HLA frequencies in Koreans |
| Q38131035 | Assessing immunologic risk factors in transplantation |
| Q94488585 | Association of Antibody-Secreting Cells With Allograft Rejection After Renal Transplantation |
| Q37643767 | Calculated PRA (CPRA): the new measure of sensitization for transplant candidates |
| Q47313617 | Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients |
| Q38079301 | Clinical relevance of antibody development in renal transplantation |
| Q35788603 | Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches |
| Q38409644 | Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction |
| Q88242265 | Comparison of Flow-cytometric Antibody Secreting Cell Assay and Mabtech Immunoglobulin ELISpot Assay |
| Q47167963 | Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events. |
| Q28075921 | Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay |
| Q38001495 | Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? |
| Q48255248 | Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation |
| Q49719376 | Differential effects of donor-specific HLA antibodies in living- versus deceased-donor transplantation. |
| Q36426146 | Donor-specific antibodies adversely affect kidney allograft outcomes. |
| Q51260684 | Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. |
| Q33993707 | Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP. |
| Q64884342 | Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients. |
| Q82978588 | Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes |
| Q38923388 | Follicular T helper cells and humoral reactivity in kidney transplant patients |
| Q49644436 | Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies |
| Q50894315 | Heart transplant with donor-specific antibody after immunoadsorption plus rituximab: a case report. |
| Q47795834 | Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation |
| Q54338277 | Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. |
| Q35332072 | Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection |
| Q93121340 | Late impact of preformed anti-HLA antibodies on kidney graft outcome |
| Q38007085 | Luminex and antibody detection in kidney transplantation |
| Q36186406 | Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients |
| Q27000194 | MHC class I signaling: new functional perspectives for an old molecule |
| Q35985731 | Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients |
| Q37894733 | Monitoring tolerance and rejection in organ transplant recipients. |
| Q44081261 | Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survival |
| Q41615009 | Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients |
| Q90704811 | Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation |
| Q40731475 | Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation |
| Q43422364 | Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation |
| Q51100534 | Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report. |
| Q82046014 | Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation |
| Q83373484 | Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates |
| Q35195122 | The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation |
| Q35865046 | The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study |
| Q52852316 | Tracing clinically relevant HLA antibodies prior to kidney transplantation: Commentary on "Pre-transplant HLA antibodies detected by single antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor specific an |
| Q35790601 | Utility of HLA Antibody Testing in Kidney Transplantation |
| Q53775002 | [Immunological monitoring in kidney transplantation: 13 years experience of a Moroccan histocompatibility laboratory]. |
Search more.